Tricuspid Valve Insufficiency Clinical Trial
Official title:
Evaluation of Liver Stiffness After Tricuspid Valvular Repair Using Magnetic Resonance Elastography
NCT number | NCT03166488 |
Other study ID # | 16-009548 |
Secondary ID | |
Status | Withdrawn |
Phase | N/A |
First received | |
Last updated | |
Start date | May 1, 2017 |
Est. completion date | December 2018 |
Verified date | June 2018 |
Source | Mayo Clinic |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to look at liver stiffness with a MRI sequence called Magnetic Resonance Elastography (MRE). The study will let the investigators know whether the subject's liver is normal or has increased stiffness. Increased liver stiffness often means there is chronic liver disease and fibrosis. Increased right heart pressure and congestive heart failure are considered risk factors for development of liver fibrosis. Liver fibrosis, if progressive, may lead to cirrhosis and its related complications. The increased liver stiffness may be due to a poorly functioning tricuspid valve. With this research, the investigators will be able to determine if the elevated stiffness of the liver returns to normal after the surgeon performs a repair or replacement of the tricuspid valve.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | December 2018 |
Est. primary completion date | June 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 100 Years |
Eligibility |
Inclusion criteria: - Primary tricuspid valvular regurgitation (tricuspid valve disease not related to a left-sided cardiac abnormality) diagnosed by echocardiography - Evidence of passive hepatic congestion. Patients with severe tricuspid regurgitation diagnosed at echocardiography will constitute evidence of passive hepatic congestion. - Patient scheduled for surgical tricuspid valvular repair or replacement. Exclusion criteria: - Contraindication for MRI (implantable devices such as cardiac pacemaker, anxiety, inability to lay supine, etc). - Additional conditions which may elevate their liver stiffness: hepatic fibrosis or cirrhosis, hepatic parenchymal disease (primary biliary cirrhosis, primary sclerosing cholangitis, etc), acute or chronic hepatitis (viral, substance or medication induced), disorders of hepatic vasculature, biliary obstruction or disease, primary or metastatic hepatic malignancy. - Cannot agree to return for a follow up visit to complete the postsurgical imaging. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Mayo Clinic |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in liver stiffness between preoperative and postoperative MR elastography (MRE) | Increased liver stiffness often means there is chronic liver disease and fibrosis. | baseline, approximately 6 months postoperatively | |
Primary | Change in tricuspid valve regurgitation measured by echocardiography | Increased liver stiffness may be due to a poorly functioning tricuspid valve. | baseline, approximately 6 months postoperatively | |
Secondary | Change in Subject Functional Capacity | Subject Functional Capacity will be measured by the Self Assessment New York Heart Association (NYHA) Classification Scale. This questionnaire consists of 4 questions regarding the subject's ability to carry on physical activities. NYHA Class I = no symptoms in regular activity; NYHA Class II = Mild symptoms and slight limitation; NYHA Class III = noticeable limitations even during minimal activity; NYHA Class IV = severe limitations even while at rest. | baseline, approximately 6 months postoperatively |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06196684 -
Early Safety and Clinical Efficacy of Mitral Allograft in Tricuspid Surgery
|
||
Not yet recruiting |
NCT03278418 -
Echo-Guided Tricuspid Valve Surgery Vs. Conservative Approach
|
N/A | |
Terminated |
NCT03632967 -
Early Feasibility Study of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System
|
N/A | |
Active, not recruiting |
NCT05724225 -
"Atriogenic Tricuspid Selected, Omics Profile, Multimodality Imaging and Clinical Outcomes"
|
||
Completed |
NCT02981953 -
TRI-REPAIR: TrIcuspid Regurgitation RePAIr With CaRdioband Transcatheter System
|
N/A | |
Completed |
NCT01444222 -
Behaviour of Tricuspid Valve Regurgitation in Volume and/or Pressure Loaded Right Heart
|
||
Recruiting |
NCT04653428 -
German Registry for Transcatheter Tricuspid Valve Interventions
|
||
Recruiting |
NCT02574650 -
Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign™.
|
N/A | |
Completed |
NCT04945005 -
Prevention of Pacemaker Lead Induced Tricuspid regurgitAtion by Transesophageal eCho guidEd Implantation Registry
|
||
Recruiting |
NCT03225612 -
Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)
|
N/A | |
Completed |
NCT01585779 -
Contour 3D®/TriAd® Tricuspid Annuloplasty Ring Post-Market Clinical Trial
|
N/A | |
Completed |
NCT03604484 -
Prophylactic Tricuspid Annuloplasty During Mitral Valve Surgery
|
N/A | |
Completed |
NCT01537458 -
Long-term Outcome After Isolated Tricuspid Valve Repair
|
||
Recruiting |
NCT05913908 -
EFS of the DUO System for Tricuspid Regurgitation (TANDEM II)
|
N/A | |
Recruiting |
NCT04436653 -
THE TRAVEL TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve
|
N/A | |
Completed |
NCT01334801 -
Biomarkers in Aortic Stenosis - B.A.S.S.
|
||
Recruiting |
NCT04735003 -
Transcatheter Interventions for Tricuspid Insufficiency in Italy
|
||
Recruiting |
NCT02314897 -
Left Ventricular Pacing to Prevent Iatrogenic TR Pilot Study
|
N/A | |
Completed |
NCT01532921 -
EASE TRICUSPID Expertise-based Assessment Study on Clinical Efficacy of Contour 3D® in TRICUSPID Valve Annuloplasty
|
||
Active, not recruiting |
NCT04614402 -
Transcatheter Repair of Tricuspid Regurgitation With Edwards PASCAL Transcatheter Valve Repair System
|